(Q31878629)

English

The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 July 2017

The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT). (English)

1 reference

Europe PubMed Central

4 July 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Freyer G

1

1 reference

Europe PubMed Central

4 July 2017

Ligneau B

2

1 reference

Europe PubMed Central

4 July 2017

Tranchand B

3

1 reference

Europe PubMed Central

4 July 2017

Ardiet C

4

1 reference

Europe PubMed Central

4 July 2017

Souquet PJ

5

1 reference

Europe PubMed Central

4 July 2017

Court-Fortune I

6

1 reference

Europe PubMed Central

4 July 2017

Riou R

7

1 reference

Europe PubMed Central

4 July 2017

Rebattu P

8

1 reference

Europe PubMed Central

4 July 2017

Morignat E

9

1 reference

Europe PubMed Central

4 July 2017

Boissel JP

10

1 reference

Europe PubMed Central

4 July 2017

Trillet-Lenoir V

11

1 reference

Europe PubMed Central

4 July 2017

Girard P

12

1 reference

Europe PubMed Central

4 July 2017

publication date

1 February 2001

1 reference

Europe PubMed Central

4 July 2017

1 reference

Europe PubMed Central

4 July 2017

31

1 reference

Europe PubMed Central

4 July 2017

2-3

1 reference

Europe PubMed Central

4 July 2017

247-256

1 reference

Europe PubMed Central

4 July 2017

Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Ran

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic studies in cancer chemotherapy: usefulness in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Variability in the pharmacokinetics of cyclophosphamide, methotrexate and 5-fluorouracil in women receiving adjuvant treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Body-surface area as a basis for dosing of anticancer agents: science, myth, or habit?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Limited sampling models for doxorubicin pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A limited-sampling strategy for estimation of etoposide pharmacokinetics in cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

High-performance liquid chromatographic analysis of the semisynthetic epipodophyllotoxins teniposide and etoposide using electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid gas chromatographic determination of ifosfamide in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetics of total and unbound etoposide.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(00)00174-4

1 reference

Europe PubMed Central

4 July 2017

1 reference

Europe PubMed Central

4 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31878629&oldid=1957322192"